You are here
Burke-Blythedale Hosts Annual Scientific Advisory Board Meeting
Pictured, left to right: Nicholas Schiff, M.D. Weill Cornell Medicine, Scientific Advisory Board Member, Burke-Blythedale Pediatric Neuroscience Collaboration; Barry Kosofsky, M.D., Ph.D., Weill Cornell Medicine, Scientific Advisory Board Member, Burke-Blythedale Pediatric Neuroscience Collaboration; N. Jeremy Hill, D.Phil., Director of Neurotechnology, Burke-Blythedale Pediatric Neuroscience Collaboration; Darryl De Vivo, M.D., Columbia University, Scientific Advisory Board Member, Burke-Blythedale Pediatric Neuroscience Collaboration; Sudhin Shah, Ph.D., Director of Cognitive Recovery Program, Burke-Blythedale Pediatric Neuroscience Collaboration; Larry Levine, President & CEO, Blythedale Children’s Hospital; Jonathan Wolpaw, M.D., Wadsworth Center, Scientific Advisory Board Member, Burke-Blythedale Pediatric Neuroscience Collaboration; Lindsey Echevarria, B.A., Senior Program Coordinator, Burke-Blythedale Pediatric Neuroscience Collaboration; David Pedowitz, Chair, Board of Trustees, Blythedale Children’s Hospital; Glen Prusky, Ph.D., Director of Vision Recovery Program, Co-Director of Burke-Blythedale Pediatric Neuroscience Collaboration; Dianna Willis, Ph.D., Associate Director of Burke Neurological Institute, Co-Director of Burke-Blythedale Pediatric Neuroscience Collaboration; Adam Kirton, M.D., MSc, University of Calgary, Scientific Advisory Board Member, Burke-Blythedale Pediatric Neuroscience Collaboration; Scott Klein, M.D., M.H.S.A., Chief Medical Officer & Chief Clinical Services Officer, Blythedale Children’s Hospital; William Mobley, M.D., Ph.D., UC, San Diego, Scientific Advisory Board Member, Burke-Blythedale Pediatric Neuroscience Collaboration; Owen Gutfreund, Board of Trustees, Blythedale Children’s Hospital; John Canning, CFO, Blythedale Children’s Hospital; Raj Ratan, M.D., Ph.D., Executive Director, Burke Neurological Institute
The annual meeting of the Scientific Advisory Board of the Burke-Blythedale Pediatric Neuroscience Research Program was held at Blythedale Children’s Hospital on December 3, 2018. The scientific advisory board is made up of national and international leaders in the fields of neuroscience, clinical medicine, and pediatrics, and leaders and board members of Burke and Blythedale.
The role of the scientific advisory board is to evaluate the direction and scientific merit of the Research Program, which ensures that research at Blythedale is relevant to the mission of the Blythedale Children’s Hospital, is accomplishing its goals, and is being conducted at the highest standards.
Four research areas were evaluated (Vision, Hemiplegia, Brain Injury and Neurotechology), and verbal and written feedback was provided for each.
By all accounts the research program was judged to be productive and highly relevant to the Burke-Blythedale mission, and feedback from the Board will be used to improve the Program research in the coming year.
